Anika Therapeutics (ANIK) Current Deferred Tax Assets (2010 - 2015)
Anika Therapeutics (ANIK) posted quarterly Current Deferred Tax Assets of $1.4 million for Q3 2015, up 113.85% year-over-year from $659040.0 in Q3 2014, and down 3.46% quarter-over-quarter from $1.5 million in Q2 2015.
Anika Therapeutics (ANIK) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Anika Therapeutics (ANIK) has reported Current Deferred Tax Assets for 6 consecutive years, with $1.4 million the latest figure, recorded in Q3 2015.
- In Q3 2015, Current Deferred Tax Assets rose 113.85% year-over-year to $1.4 million; the TTM figure through Sep 2015 stood at $1.4 million (up 113.85% YoY), while the FY2014 annual figure was $1.2 million, up 80.38% from the prior year.
- Current Deferred Tax Assets declined to $1.4 million in Q3 2015 per ANIK's latest filing, from $1.5 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $2.0 million in Q4 2012 and bottomed at $659040.0 in Q4 2013.
- Historically, Current Deferred Tax Assets has averaged $1.5 million across 5 years, with a median of $1.9 million in 2011.
- Annual changes were most pronounced in 2013 — Current Deferred Tax Assets slumped 67.56% — and 2015, when it jumped 125.76%.
- Anika Therapeutics' Current Deferred Tax Assets stood at $1.9 million in 2011, then increased by 5.87% to $2.0 million in 2012, then plunged by 67.56% to $659040.0 in 2013, then soared by 80.38% to $1.2 million in 2014, then gained by 18.55% to $1.4 million in 2015.
- Business Quant data shows ANIK's Current Deferred Tax Assets at $1.4 million in Q3 2015, $1.5 million in Q2 2015, and $1.5 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Anika Therapeutics | 286.14 Mn | 247.73 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 1.41 Mn |
| Sep 30, 2015 | 1.41 Mn |
| Jun 30, 2015 | 1.46 Mn |
| Jun 30, 2015 | 1.46 Mn |
| Mar 31, 2015 | 1.49 Mn |
| Mar 31, 2015 | 1.49 Mn |
| Dec 31, 2014 | 1.19 Mn |
| Dec 31, 2014 | 1.19 Mn |
| Sep 30, 2014 | 659,040.00 |
| Sep 30, 2014 | 659,040.00 |
| Jun 30, 2014 | 659,040.00 |
| Jun 30, 2014 | 659,040.00 |
| Mar 31, 2014 | 659,040.00 |
| Mar 31, 2014 | 659,040.00 |
| Dec 31, 2013 | 659,040.00 |
| Dec 31, 2013 | 659,040.00 |
| Sep 30, 2013 | 1.99 Mn |
| Sep 30, 2013 | 1.99 Mn |
| Jun 30, 2013 | 1.99 Mn |
| Jun 30, 2013 | 1.99 Mn |